Ashley Sizemore

Ms. Ashley Sizemore

Human Studies, University of Alabama at Birmingham, Birmingham, Alabama, USA
orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Christopher G BallmannChristopher G Ballmann
Christopher G Ballmann
DSDaphne Schmid
Daphne Schmid
MPMaggie Pitts
Maggie Pitts
EPEmily Pounds
Emily Pounds
Ashley SizemoreAshley Sizemore
Ashley Sizemore
Shelby OsburnShelby Osburn
Shelby Osburn
Alzheimer’s disease (AD) results in progressive neural degeneration that causes cognitive and non-cognitive symptoms (NCSs). While cognitive symptoms commonly prompt a formal diagnosis, NCSs also contribute significantly to disability, caregiver burden, and overall disease progression. NCSs are rooted in both physiological and psychological consequences of AD, resulting in apathy/motivation loss, emotional dysregulation, anxiety, depression, agitation, and sleep disturbances. Despite progresses in pharmaceutical management of NCSs, variable efficacy, unwanted side effects, and lack of symptom-wide effectiveness often limit therapeutic practicality for people with AD, suggesting a need for the identification of practical adjunctive treatments. Mechanistic evidence of using music interventions as complementary treatment to manage cognitive symptoms in AD has been established, but the potential benefits for NCSs are less clear. Music interventions have the potential to adaptatively alter mechanisms underlying NCSs that span both physiological and psychological domains of symptomology. Physiologically, music has been shown to alter autonomic activity, neurotransmitter release in various brain regions, and mediate hormonal regulation. Psychologically, music interventions have been shown to enhance mechanisms related to motivation, emotional regulation, and resilience to mental stress. Behavioral and neuroimaging evidence further supports this and suggests that the mechanisms of music-induced benefits may aid in counteracting NCSs in people with AD. While the neuromechanistic rationale for music-induced benefits towards NCSs in AD is promising, findings are largely fragmented, leaving therapeutic application difficult. Accordingly, the purpose of this review is to integrate current mechanistic evidence and clinical findings for a rationale and framework for the therapeutic application of music interventions to combat NCSs in AD. Overall, evidence largely supports the use of music as an adjunctive, feasible, and non-invasive therapeutic tool to improve various aspects of NCSs in AD. The translation of mechanistic findings to therapeutic utility are further highlighted. Limitations, challenges, and future directions necessary to fully realize music benefits on NCSs in AD are also discussed with a goal of therapeutic translation.

1 September 2026 in Journal of Phytomedicine
Verified
Journal Article
Open access
PDF file
DSDaphne Schmid
Daphne Schmid
MPMaggie Pitts
Maggie Pitts
Ashley SizemoreAshley Sizemore
Ashley Sizemore
Christopher G BallmannChristopher G Ballmann
Christopher G Ballmann
Adaptogens are a group of bioactive substances that are purported to enhance non-specific resistance to stress and promote physiological homeostasis. Adaptogens are typically derived from specific medicinal plants or fungi, with many having been used in folk medicine for centuries for their stress-reducing properties. Emerging evidence has shown that adaptogens modulate various aspects of stress responses through hormonal, neural, and cellular mechanisms, which are highly relevant to performance and responses to exercise. Adaptogens may exert ergogenic effects by modulating fatigue, autonomic balance, neuromuscular function, and metabolic responses during exercise. Collectively, evidence has suggested that adaptogens have the potential to improve responses to exercise and enhance performance during aerobic, sprint, and resistance modes of activity. Despite promising findings, the current body of literature is highly fragmented, heterogeneous in study design, and has largely failed to bridge the gap between mechanisms in preclinical models and applicable exercise performance outcomes in humans. Furthermore, the psychophysiological underpinning of potential improvements to exercise responses remains less described. The purpose of this narrative review is to synthesize current evidence of adaptogens, supplementation, and responses to exercise as it pertains to performance, physiological, and psychological domains. Particularly, adaptogen supplements (i.e., Rhodiola Rosea, Ashwagandha, Cordyceps, Panax ginseng), which are commercially available and prominent in the exercise literature, are highlighted. Information related to dosing, effectiveness, and underlying mechanisms of action are discussed with an emphasis on how this influences psychophysiological responses to exercise. Lastly, future research needs and limitations based on the current literature are discussed. Despite some promising evidence of the ergogenic effects of adaptogens, this review highlights the need for additional well-controlled studies with more emphasis on psychophysiological mechanisms before widespread recommendations for their use can be made.